Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Infections × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 53 Neoplasms 49 Prostatic Neoplasms 38 Lung Neoplasms 30 Colorectal Neoplasms 30 Carcinoma, Non-Small-Cell Lung 21 Hematologic Neoplasms 18 Pancreatic Neoplasms 16 Neoplasm Metastasis 14 Head and Neck Neoplasms 14 Urinary Bladder Neoplasms 11 Motor Activity 10 Stomach Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 9 Multiple Myeloma 9 Ovarian Neoplasms 8 Melanoma 8 Anxiety Disorders 8 Triple Negative Breast Neoplasms 7 Hematopoietic and Lymphatic System Neoplasm 7 Glioma 7 Colonic Neoplasms 7 Sarcoma 6 Glioblastoma 6 Gastrointestinal Neoplasms 6 Esophageal Neoplasms 6 Carcinoma, Renal Cell 6 Rectal Neoplasms 5 Mouth Neoplasms 5 Lymphoma 5

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 8 Ciprofloxacin 6 Fluconazole 3 Daptomycin 3 Antibiotic Prophylaxis 3 gamma-Globulins 2 Voriconazole 2 Vancomycin 2 Trimethoprim 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Melphalan 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Fosfomycin 2 Ethanol 2 Cyclophosphamide 2 Cefazolin 2 Amoxicillin-Potassium Clavulanate Combination 2 ziprasidone 1 tocilizumab 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1 peginterferon alfa-2a 1 monalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333914 2022-09-30

IMMUNONCOVID

Centre Leon Berard

Phase 2 Completed

COVID-19, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡